Enveric Biosciences, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Enveric Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2024.
  • Enveric Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$1.88M, a 70.4% increase year-over-year.
  • Enveric Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$10.6M, a 52.3% increase year-over-year.
  • Enveric Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$17.3M, a 6.39% increase from 2022.
  • Enveric Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$18.5M, a 62.3% increase from 2021.
  • Enveric Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$49M, a 613% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$10.6M -$1.88M +$4.48M +70.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$15.1M -$2.46M +$2.22M +47.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-12
Q4 2023 -$17.3M -$3.44M +$5.24M +60.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 -$22.5M -$2.82M -$343K -13.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$22.2M -$6.36M -$3.57M -128% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$18.6M -$4.68M -$154K -3.39% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-12
Q4 2022 -$18.5M -$8.68M +$33.4M +79.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 -$51.9M -$2.48M +$233K +8.61% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$52.1M -$2.79M -$1.88M -207% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$50.3M -$4.52M -$1.27M -39.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$49M -$42.1M -$37.7M -861% Oct 1, 2021 Dec 31, 2021 10-K/A 2023-06-09
Q3 2021 -$11.3M -$2.71M -$2.15M -380% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$9.11M -$908K -$89.9K -11% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$9.02M -$3.25M -$2.15M -196% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$6.86M -$4.38M -$5.05M -759% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$1.82M -$565K -$607K -1469% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$1.21M -$818K +$438K +34.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$1.65M -$1.1M +$762K +40.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
Q4 2019 -$2.41M $665K +$20.4M Oct 1, 2019 Dec 31, 2019 10-K 2021-04-01
Q3 2019 -$22.8M $41.3K -$5.66M -99.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$17.2M -$1.26M +$3.65K +0.29% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$17.2M -$1.86M -$288K -18.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$16.9M -$19.8M -$18.8M -1865% Oct 1, 2018 Dec 31, 2018 10-K/A 2020-08-12
Q3 2018 $1.86M $5.7M +$9.77M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$7.91M -$1.26M +$2.02M +61.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$9.92M -$1.57M -$850K -118% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$9.07M -$1.01M -$2.37M -174% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-26
Q3 2017 -$6.7M -$4.07M -$2.29M -129% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$4.41M -$3.28M -$2.07M -171% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$2.34M -$722K +$438K +37.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$2.78M $1.37M +$3.21M Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$5.99M -$1.78M -$1.62M -1014% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$4.37M -$1.21M -$1.32M -1190% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$3.05M -$1.16M -$2.24M -208% Jan 1, 2016 Mar 31, 2016 10-Q/A 2017-05-15
Q4 2015 -$814K -$1.84M -$1.41M -327% Oct 1, 2015 Dec 31, 2015 10-K/A 2017-04-04
Q3 2015 $597K -$160K -$156K -4920% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $754K $111K -$297K -72.8% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 $1.05M $1.08M +$1.08M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$33.6K -$431K Oct 1, 2014 Dec 31, 2014 10-K 2015-03-31
Q3 2014 -$3.18K +$1.38K +30.3% Jul 1, 2014 Sep 30, 2014 10-Q/A 2014-11-14
Q2 2014 $408K +$412K Apr 1, 2014 Jun 30, 2014 10-Q/A 2015-08-18
Q1 2014 -$7.87K -$3.17K -67.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q3 2013 -$24.8K -$4.56K +$309 +6.35% Jul 1, 2013 Sep 30, 2013 10-Q/A 2014-11-14
Q2 2013 -$25.1K -$3.89K +$190 +4.66% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 -$25.3K -$4.7K -$653 -16.1% Jan 1, 2013 Mar 31, 2013 10-Q/A 2014-05-08
Q4 2012 -$24.6K -$11.6K +$3.35K +22.4% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-28
Q3 2012 -$28K -$4.87K -$1.18K -32% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-06
Q2 2012 -$26.8K -$4.08K -$450 -12.4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-01
Q1 2012 -$26.3K -$4.05K +$7.04K +63.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-02
Q4 2011 -$33.4K -$15K Oct 1, 2011 Dec 31, 2011 10-K 2013-02-28
Q3 2011 -$3.69K +$1.93K +34.3% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$3.63K -$3.63K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-01
Q1 2011 -$11.1K Jan 1, 2011 Mar 31, 2011 10-Q/A 2012-05-10
Q3 2010 -$5.61K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 $0 Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.